Role of Dual-Energy X-Ray Absorptiometry in the Diagnosis and Treatment of Osteoporosis

Journal of Clinical Densitometry

Volumn 10, Issue 1, 2007, Pages 102-110

  Blake, Glen M ^a   Fogelman, Ignac ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bone mineral density; dual energy X ray absorptiometry; fracture risk; osteoporosis treatment

Indexed keywords

ALENDRONIC ACID; IBANDRONIC ACID; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID; STRONTIUM RANELATE; ZOLEDRONIC ACID;

ALGORITHM; BONE DENSITY; COMPUTER ASSISTED TOMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; FRACTURE; HIGH RISK POPULATION; HIP; HUMAN; INTERMETHOD COMPARISON; OSTEOPOROSIS; PATIENT COUNSELING; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SPINE; SYSTEMATIC REVIEW; TREATMENT RESPONSE; ULTRASOUND; WORLD HEALTH ORGANIZATION;

ALGORITHMS; DENSITOMETRY, X-RAY; HIP FRACTURES; HUMANS; OSTEOPOROSIS; RISK ASSESSMENT; ROC CURVE;

EID: 33846669092     PISSN: 10946950     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocd.2006.11.001     Document Type: Review

References (56)

1. Bone health and osteoporosis: a report of the Surgeon General. Issued October 2004. Available online at. www.surgeongeneral.gov/library/bonehealth
2. Stone K.L., Seeley D.G., Lui L.-Y., et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res 18 (2003) 1947-1954
3. Ray N.F., Chan J.K., Thamer M., and Melton L.J. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12 (1997) 24-35
4. Cooper C., Atkinson E.J., Jacobsen S.J., O'Fallon M., and Melton L.J. Population based study of survival after osteoporotic fractures. Am J Epidemiol 137 (1993) 1001-1005
5. Genant H.K., Engelke K., Fuerst T., et al. Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res 11 (1996) 707-730
6. Blake G.M., and Fogelman I. Technical principles of dual energy X-ray absorptiometry. Semin Nucl Med 27 (1997) 210-228
7. Storm T., Thamsborg G., Steiniche T., Genant H.K., and Sorensen O.H. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 322 (1990) 1265-1271
8. Kanis J.A., Melton J., Christiansen C., Johnston C.C., and Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 9 (1994) 1137-1141
9. Black D.M., Cummings S.R., Karpf D.B., et al. Randomised trial of the effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348 (1996) 1535-1541
10. Cummings S.R., Black D.M., Thompson D.E., et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280 (1998) 2077-2082
11. Harris S.T., Watts N.B., Genant H.K., et al. Effects of risedronate treatment on vertebral and non-vertebral fractures in women with postmenopausal osteoporosis. JAMA 282 (1999) 1344-1352
12. McClung M.R., Geusens P., Miller P.D., et al. Effect of risedronate treatment on hip fracture risk in elderly women. N Engl J Med 344 (2001) 333-340
13. Chesnut C.H., Skag A., Christiansen C., et al. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 19 (2004) 1241-1249
14. Black D.M., Boonen S., Cauley J., et al. Effect of once-yearly infusion of zolendronic acid 5 mg on spine and hip fracture reduction in postmenopausal women with osteoporosis: the HORIZON pivotal fracture trial. J Bone Miner Res 21 Suppl 1 (2006) S16
15. Ettinger B., Black D.M., Mitlak B.H., et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomised clinical trial. JAMA 282 (1999) 637-645
16. Neer R.M., Arnaud C.D., Zanchetta J.R., et al. Effect of recombinant human parathyroid hormone (1-34) fragment on spine and non-spine fractures and bone mineral density in postmenopausal osteoporosis. N Engl J Med 344 (2001) 1434-1441
17. Meunier P.J., Roux C., Seeman E., et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350 (2004) 459-468
18. Reginster J.Y., Seeman E., De Vernejoul M.C., et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: TROPOS study. J Clin Endocrinol Metab 90 (2005) 2816-2822
19. Seeman E., Vellas B., Benhamou C., et al. Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res 21 (2006) 1113-1120
20. Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D, on behalf of the European Foundation for Osteoporosis and Bone Disease 1997 Guidelines for diagnosis and treatment of osteoporosis. Osteoporos Int 7:390-406
21. Genant H.K., Cooper C., Poor G., et al. Interim report and recommendations of the World Health Organization task-force for osteoporosis. Osteoporos Int 10 (1999) 259-264
22. Marshall D., Johnell O., and Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312 (1996) 1254-1259
23. Gluer C.-C. Monitoring skeletal change by radiological techniques. J Bone Miner Res 14 (1999) 1952-1962
24. Fogeman I., and Blake G.M. Different approaches to bone densitometry. J Nucl Med 41 (2000) 2015-2025
25. Guglielmi G., and Lang T.F. Quantitative computed tomography. Semin Musculoskelet Radiol 6 (2002) 219-227
26. Lang T.F., Guglielmi G., Van Kuijk C., De Serio A., Cammisa M., and Genant H.K. Measurement of vertebral bone mineral density at the spine and proximal femur by volumetric quantitative computed tomograph and dual-energy X-ray absorptiometry in elderly women with and without vertebral fractures. Bone 30 (2002) 247-250
27. Blake G.M., and Fogelman I. Clinical use of instruments that measure peripheral bone mass. Curr Opin Endocrinol Diabetes 9 (2002) 502-511
28. Stewart A., and Reid D.M. Quantitative ultrasound in osteoporosis. Semin Musculoskelet Radiol 6 (2002) 229-232
29. Lu Y., Genant H.K., Shepherd J., et al. Classification of osteoporosis based on bone mineral densities. J Bone Miner Res 16 (2001) 901-910
30. Faulkner K.G., Von Stetton E., and Miller P. Discordance in patient classification using T-scores. J Clin Densitom 2 (1999) 343-350
31. Blake G.M., and Fogelman I. Peripheral or central densitometry: does it matter which technique we use?. J Clin Densitom 4 (2001) 83-96
32. Blake G.M., and Fogelman I. Bone densitometry and fracture risk prediction. Eur J Nucl Med 31 (2004) 785-786
33. Cummings S.R., Black D.M., Nevitt M.C., et al. Bone density at various sites for prediction of hip fractures. Lancet 341 (1993) 72-75
34. Black D.M., Palermo L., and Bauer D. How well does bone mass predict long-term risk of hip fracture?. Osteoporosis Int 11 Suppl 2 (2000) S59
35. Orwoll E.S., Marshall L.M., Chan B.K., et al. Measures of hip structure are important determinants of hip fracture risk independent of BMD. J Bone Miner Res 20 Suppl 1 (2006) S35
36. Bauer D.C., Gluer C.-C., Cauley J.A., et al. Broadband ultrasonic attenuation predicts fractures strongly and independently of densitometry in older women. Arch Intern Med 157 (1997) 629-634
37. Hans D., Dargent-Molina P., Schott A.M., et al. Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 348 (1996) 511-514
38. Woodhouse A., and Black D.M. BMD at various sites for the prediction of hip fracture: a meta-analysis. J Bone Miner Res 15 Suppl 2 (2000) S145
39. Pluijm S.M.F., Graafmans W.C., Bouter L.M., and Lips P. Ultrasound measurements for the prediction of osteoporotic fractures in elderly people. Osteoporos Int 9 (1999) 550-556
40. Khaw K.-T., Reeve J., Luben R., et al. Prediction of total and hip fracture risk in men and women by quantitative ultrasound of the calcaneus: EPIC-Norfolk prospective population study. Lancet 363 (2004) 197-202
41. Miller P.D., Siris E.S., Barrett-Connor E., et al. Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment. J Bone Miner Res 17 (2002) 2222-2230
42. Bauer D.C., Palermo L., Black D.M., Hillier T.A., and Cauley J.A. A prospective study of dry calcaneal quantitative ultrasound and fracture risk in older women: the Study of Osteoporotic Fractures. J Bone Miner Res 16 Suppl 1 (2001) S166
43. Looker A.C., Wahner H.W., Dunn W.L., et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8 (1998) 468-489
44. Official positions of the International Society for Clinical Densitometry: updated. Available online at, www.iscd.org/visitors/positions/official.cfm.
45. Faulkner K.G., Roberts L.A., and McClung M.R. Discrepancies in normative data between Lunar and Hologic DXA systems. Osteoporosis Int 6 (1996) 432-436
46. Hanson J. Standardization of femur BMD. J Bone Miner Res 12 (1997) 1316-1317
47. Blake G.M., Chinn D.J., Steel S.A., et al. A list of device specific thresholds for the clinical interpretation of peripheral x-ray absorptiometry examinations. Osteoporos Int 16 (2005) 2149-2156
48. Johnell O., Kanis J.A., Oden A., et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res 20 (2005) 1185-1194
49. Kanis J.A., Borgstrom F., De Laet C., et al. Assessment of fracture risk. Osteoporos Int 16 (2005) 581-589
50. De Laet C., Oden A., Johansson H., Johnell O., Jonsson B., and Kanis J.A. The impact of the use of multiple risk factors for fracture on case-finding strategies: a mathematical approach. Osteoporosis Int 16 (2005) 313-318
51. Borgstrom F., Johnell O., Kanis J.A., et al. At what hip fracture risk is it cost effective to treat? International intervention thresholds for the treatment of osteoporosis. Osteoporos Int 17 (2006) 1459-1471
52. Kanis J.A., Johnell O., Oden A., et al. The use of multiple sites for the diagnosis of osteoporosis. Osteoporos Int 17 (2006) 527-534
53. Patel R., Blake G.M., Rymer J., and Fogelman I. Long-term precision of DXA scanning assessed over seven years in forty postmenopausal women. Osteoporos Int 11 (2000) 68-75
54. Eastell R. Treatment of postmenopausal osteoporosis. N Engl J Med 338 (1998) 736-746
55. Faulkner K.G. Bone densitometry: choosing the proper site to measure. J Clin Densitom 1 (1998) 279-285
56. Blake G.M., Herd R.J.M., and Fogelman I. A longitudinal study of supine lateral DXA of the lumbar spine: a comparison with posteroanterior spine, hip and total body DXA. Osteoporos Int 6 (1996) 462-470